- Home
- CMPX vs ENX Comparison
CMPX vs ENX Comparison
Compare CMPX & ENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- ENX
- Stock Information
- Founded
- CMPX 2014
- ENX 2002
- Country
- CMPX United States
- ENX United States
- Employees
- CMPX N/A
- ENX N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- ENX Finance/Investors Services
- Sector
- CMPX Health Care
- ENX Finance
- Exchange
- CMPX Nasdaq
- ENX Nasdaq
- Market Cap
- CMPX 217.4M
- ENX 178.4M
- IPO Year
- CMPX N/A
- ENX N/A
- Fundamental
- Price
- CMPX $1.63
- ENX $9.99
- Analyst Decision
- CMPX Strong Buy
- ENX
- Analyst Count
- CMPX 3
- ENX 0
- Target Price
- CMPX $7.67
- ENX N/A
- AVG Volume (30 Days)
- CMPX 410.9K
- ENX 25.4K
- Earning Date
- CMPX 11-07-2024
- ENX 01-01-0001
- Dividend Yield
- CMPX N/A
- ENX 3.94%
- EPS Growth
- CMPX N/A
- ENX N/A
- EPS
- CMPX N/A
- ENX 0.16
- Revenue
- CMPX $850,000.00
- ENX N/A
- Revenue This Year
- CMPX N/A
- ENX N/A
- Revenue Next Year
- CMPX $950.68
- ENX N/A
- P/E Ratio
- CMPX N/A
- ENX $61.00
- Revenue Growth
- CMPX N/A
- ENX N/A
- 52 Week Low
- CMPX $0.77
- ENX $7.84
- 52 Week High
- CMPX $2.34
- ENX $10.07
- Technical
- Relative Strength Index (RSI)
- CMPX 62.58
- ENX 54.70
- Support Level
- CMPX $1.42
- ENX $9.86
- Resistance Level
- CMPX $1.86
- ENX $10.08
- Average True Range (ATR)
- CMPX 0.15
- ENX 0.07
- MACD
- CMPX 0.01
- ENX 0.01
- Stochastic Oscillator
- CMPX 62.09
- ENX 56.52
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.